The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.
Despite the emerging success of multi-targeted protein tyrosine kinase (PTK) inhibitors in cancer therapy, significant side effects and resistance concerns seems to be avoided unlikely. The aim of the present study was to identify novel multi-targeting PTK inhibitors. The kinase enzymatic activities...
Main Authors: | Jingui Ma, Xianliang Xin, Linghua Meng, Linjiang Tong, Liping Lin, Meiyu Geng, Jian Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2582481?pdf=render |
Similar Items
-
Some preliminary questions regarding the mdos rituals
by: Anne-Marie Blondeau
Published: (2022-01-01) -
Introduction to the translation of ‘Some preliminary questions regarding the mdos rituals’ by A-M Blondeau
by: Charles Ramble
Published: (2022-01-01) -
Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.
by: Claire L Cole, et al.
Published: (2010-07-01) -
Acidic Oligosaccharide Sugar Chain, a Marine-Derived Acidic Oligosaccharide, Inhibits the Cytotoxicity and Aggregation of Amyloid Beta Protein
by: Jinfeng Hu, et al.
Published: (2004-01-01) -
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
by: Shuang Qin, et al.
Published: (2019-03-01)